Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.63 Billion | USD 4.34 Billion | 11.5% | 2023 |
The global Automated Cannabis Testing Market size was worth around USD 1.63 billion in 2023 and is predicted to grow to around USD 4.34 billion by 2032 with a compound annual growth rate (CAGR) of roughly 11.5% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Automated Cannabis Testing Market on a global and regional level.
The global automated cannabis testing market has enormous opportunities in the upcoming future. The global automated cannabis testing market is expected to grow at a significant rate within the forecast period. The growth of the automated cannabis testing market can be attributed to the increasing adoption of laboratory information management system (LIMS) in automated cannabis testing as LIMS is an extremely powerful tool for testing cannabis in laboratories. Also, the increasing number of cannabis testing labs in prominent countries such as U.S., Canada, etc. coupled with the legalization of cannabis for medical distribution is expected to propel the market growth over the forecast years. Moreover, the rising number of medical cannabis clubs and awareness of medical benefits related to the consumption of cannabis is expected to bolster the growth of the automated cannabis testing market over the forecast years.
Based on the product type, the global automated cannabis testing market has been classified into chromatography based analyzer type and spectroscopy-based analyzer type. Chromatography based analyzer type held the largest market share in 2023. Chromatography based analyzer type segment is anticipated to grow at a rapid pace on account of its fast and effective results. In addition to this, various key players are also offering specialized chromatography instruments in the market for cannabis testing, which is expected to further the growth of chromatography based analyzer type segment over the forecast years.
On the basis of application, the global automated cannabis testing market is segmented into pain management, seizures, sclerosis, and others. Among these, the pain management segment holds the maximum segment share currently and is expected to witness significant growth over the forecast period. Usage of cannabis in treating diseases such as chronic pain, arthritis, neurological disorders, and other diseases is expected to stimulating the growth of this segment over the forecast years. Also, the increasing need for effective pain management remedies on a global scale is expected to boost the demand for automated cannabis testing market over the forecast timeframe.
Based on end-use, the global automated cannabis testing market has been segmented into consumers, regulators, laboratories, and others. The laboratories segment held the largest market share in 2018, on account of an increasing number of cannabis testing laboratories across the globe.
Report Attributes | Report Details |
---|---|
Report Name | Automated Cannabis Testing Market |
Market Size in 2023 | USD 1.63 Billion |
Market Forecast in 2032 | USD 4.34 Billion |
Growth Rate | CAGR of 11.5% |
Number of Pages | 110 |
Key Companies Covered | Medicinal Genomics Corp., Hamilton Company, PerkinElmer Inc., Agilent Technologies Inc |
Segments Covered | By Product, By Application and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Based on the region, North America held the largest market share in 2023 owing to the increasing legalization for the distribution of cannabis as a medical product across the region. Moreover, the rising number of testing laboratories and increasing cannabis cultivation across the region is expected to accelerate regional market growth over the forecast years. Europe is projected to witness a remarkable market growth during the forecast period. This can be attributed to the new medical cannabis legislation and approval of the production license since March 2017. Also, the rising demand for medical cannabis among patients and prescribers is expected to further propel the growth of automated cannabis testing market in Europe over the forecast timeline.
By Product Type
By Application
By End-Use
Global Automated Cannabis Testing Market: Regional Segment Analysis
FrequentlyAsked Questions
Automated cannabis testing refers to the use of advanced technologies and systems to conduct quality control and safety assessments on cannabis products.
According to study, the Automated Cannabis Testing Market size was worth around USD 1.63 billion in 2023 and is predicted to grow to around USD 4.34 billion by 2032.
The CAGR value of Automated Cannabis Testing Market is expected to be around 11.5% during 2024-2032.
Europe has been leading the Automated Cannabis Testing Market and is anticipated to continue on the dominant position in the years to come.
The Automated Cannabis Testing Market is led by players like Medicinal Genomics Corp., Hamilton Company, PerkinElmer Inc., Agilent Technologies Inc.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed